Artículos por temáticas

Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.

López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P; on behalf of the VALGAS investigators group..

Eur Neurol. 2019 Nov 14:1-8. doi: 10.1159/000503172. [Epub ahead of print]

The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.

Choi JY, Kim SK, Park ES.

Toxins (Basel). 2019 Nov 8;11(11). pii: E651. doi: 10.3390/toxins11110651.

The effectiveness of extracorporeal shock wave therapy to reduce lower limb spasticity in stroke patients: a systematic review and meta-analysis

Cabanas-Valdés R, Calvo-Sanz J, Urrùtia G, Serra-Llobet P, Pérez-Bellmunt A, Germán-Romero A.

Top Stroke Rehabil. 2020 Mar;27(2):137-157. doi: 10.1080/10749357.2019.1654242. Epub 2019 Nov 11.

Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy

Ro T, Ota T, Saito T, Oikawa O.

J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104481. doi: 10.1016/j.jstrokecerebrovasdis.2019.104481. Epub 2019 Nov 4.

Pain in adults with cerebral palsy: measuring the contribution of spasticity

Smith JMC, Field TS.

Dev Med Child Neurol. 2020 Mar;62(3):271. doi: 10.1111/dmcn.14396. Epub 2019 Nov 7.

Intrathecal Baclofen Dosage for Long-Term Treatment of Patients With Spasticity Due to Traumatic Spinal Cord Injuries or Multiple Sclerosis.

Skoog B, Hedman B.

Ann Rehabil Med. 2019 Oct;43(5):555-561. doi: 10.5535/arm.2019.43.5.555. Epub 2019 Oct 31.

Effects of a 3D-printed orthosis compared to a low-temperature thermoplastic plate orthosis on wrist flexor spasticity in chronic hemiparetic stroke patients: a randomized controlled trial

Zheng Y, Liu G, Yu L, Wang Y, Fang Y, Shen Y, Huang X, Qiao L, Yang J, Zhang Y, Hua Z.

Clin Rehabil. 2020 Feb;34(2):194-204. doi: 10.1177/0269215519885174. Epub 2019 Nov 5.

Management of Muscle Spasticity in Children with Cerebral Palsy by Means of Extracorporeal Shockwave Therapy: A Systematic Review of the Literature

Corrado B, Di Luise C, Servodio Iammarrone C.

Dev Neurorehabil. 2021 Jan;24(1):1-7. doi: 10.1080/17518423.2019.1683908. Epub 2019 Nov 1.

Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson’s disease.

Guerra A, Suppa A, D’Onofrio et al.

Brain Stimul 2019 [EPub ahead of print]

Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

Hurt CS, Rixon L, Chaudhuri KR, et al.

Parkinsonism Relat Disord 2019

How to diagnose parkinsonian central pain?

Marques A, Attal N, Bouhassira D, et al.

Parkinsonism Relat Disord 2019 [EPub ahead of print]

Levodopa Is the Best Symptomatic Therapy for PD: Nothing More, Nothing Less.

Olanow W.

Mov Disord 2019 EPub ahead of print]

Are all dopamine agonists essentially the same?

Torti M, Bravi , Vacca L, et al.

Drugs 2019;79(7):693-703.

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Martí-Andrés G, Jiménez-Bolaños R, Arbelo-González JM, et al.

Brain Sci 2019 [EPub ahead of print]

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients

Cattaneo C, Wolfgang H, Bonizzoni E.

J Parkinsons Dis 2019 [EPub ahead of print]